The store will not work correctly when cookies are disabled.
9-{2-[(4-Amino-but-2-enyl)-methyl-amino]-ethoxymethyl}-9H-purine-2,6-diamine
ID: ALA150227
PubChem CID: 44365216
Max Phase: Preclinical
Molecular Formula: C13H22N8O
Molecular Weight: 306.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C/C=C\CN)CCOCn1cnc2c(N)nc(N)nc21
Standard InChI: InChI=1S/C13H22N8O/c1-20(5-3-2-4-14)6-7-22-9-21-8-17-10-11(15)18-13(16)19-12(10)21/h2-3,8H,4-7,9,14H2,1H3,(H4,15,16,18,19)/b3-2-
Standard InChI Key: PLEWJPRWVRRPSU-IHWYPQMZSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
8.1792 -3.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1792 -2.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9667 -3.5417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4625 -3.7042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9667 -2.2042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7417 -2.4625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4625 -2.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7417 -3.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4500 -2.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9250 -5.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4542 -1.2250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0292 -3.7000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7042 -5.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8917 -5.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1917 -5.5167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6167 -5.8500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2542 -4.7375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3542 -5.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4042 -6.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8042 -4.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3667 -6.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5917 -5.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 2 1 0
6 8 1 0
7 2 1 0
8 4 2 0
9 3 1 0
10 3 1 0
11 7 1 0
12 8 1 0
13 18 1 0
14 13 2 0
15 20 1 0
16 19 1 0
17 10 1 0
18 15 1 0
19 14 1 0
20 22 1 0
21 15 1 0
22 17 1 0
9 5 2 0
6 7 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 306.37 | Molecular Weight (Monoisotopic): 306.1917 | AlogP: -0.59 | #Rotatable Bonds: 8 |
Polar Surface Area: 134.13 | Molecular Species: BASE | HBA: 9 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 9.68 | CX LogP: -0.65 | CX LogD: -3.97 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.44 | Np Likeness Score: -0.68 |
References
1. Marasco CJ, Kramer DL, Miller J, Porter CW, Bacchi CJ, Rattendi D, Kucera L, Iyer N, Bernacki R, Pera P, Sufrin JR.. (2002) Synthesis and evaluation of analogues of 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine as inhibitors of tumor cell growth, trypanosomal growth, and HIV-1 infectivity., 45 (23): [PMID:12408722] [10.1021/jm0201621] |